Brian has long said that health care needs a start, not a finish. With the passage of the 2009 Patient Protection and Affordable Care Act, our nation took a critical first step by giving millions of Americans access to health insurance, including those who had never had access before, like individuals with pre-existing conditions, and making sure that the high cost of medical treatments do not force families into bankruptcy. Brian supports efforts in Congress to come together across the aisle and improve the law, bringing down the cost curve and making the quality of care better for all Americans.
More on Health Care
During a House Ways and Means Committee hearing titled “Pathways to Universal Health Coverage,” Congressman Brian Higgins (NY-26) discussed the importance of defending pre-existing conditions protections codified in the Affordable Care Act, and stressed that the Medicare model, which has proven to provide quality, cost-effective healthcare, should be available to more Americans.
During his remarks, Congressman Higgins said:
Congressman Brian Higgins (NY-26) announced the House of Representatives passed H.R. 987, The Strengthening Health Care and Lowering Prescription Drug Costs Act, by a vote of 234-183. The legislation combines seven bills that take action to lower the costs of prescription drugs as well as promote competition from generic alternatives. The omnibus package also includes provisions to stabilize insurance markets and rescind an October rule allowing for the expansion of “junk plans” that do not cover preexisting conditions or provide essential benefits.
The legislation includes:
Congressman Brian Higgins (D-NY-26) was joined by representatives from People Inc., Western New York Independent Living and the National Coalition for Assistive & Rehab Technology to announce federal legislation to make it easier for individuals with significant disabilities and chronic medical conditions to access specialized wheelchairs and adaptive equipment technology. Reps. Higgins and Jim Sensenbrenner (R-WI-05) have introduced H.R.
Congressman Brian Higgins (NY-26) was joined by the VA Western New York Healthcare System (VAWNYHS) Executive Director Michael J. Swartz and Associate Chief of Staff for Research and Professor of Medicine, Anesthesiology and Environmental Health at the University of Buffalo, Dr. Ali El-solh, to announce federal grants from the Department of Veterans Affairs supporting three separate research projects at the Buffalo VA Medical Center. The three grants represent a total of $2,413,635 in funding awarded to the Buffalo VA.
Congressman Brian Higgins (NY-26) announced approval in the House of Representatives of H.Res. 271, a resolution condemning the Trump Administration’s legal attack on America’s health care.
Last week the U.S. Department of Justice pursued court action to invalidate the Affordable Care Act in its entirety and throughout the week the President reignited rhetoric calling for abolishing the health coverage that has been available to all Americans since 2014.
ring a House Budget Committee hearing with the Department of Health and Human Services Deputy Secretary Eric Hargan, Congressman Brian Higgins (NY-26) raised serious questions about the rationale of cutting hundreds of millions of dollars in cancer research funding from the 2020 budget.
Congressman Brian Higgins (NY-26) announced millions of dollars in federal funding to support the research of Krabbe leukodystrophy, known as Krabbe Disease (KD). A grant from the National Institutes of Health (NIH) in the amount of $433,627 in the first year and over $2 million over a five-year period has been awarded to M. Laura Feltri, MD and Lawrence Wrabetz, MD, co-directors of the Hunter James Kelly Research Institute at the University at Buffalo (UB).
Congressmembers Brian Higgins (D -NY-26), Brett Guthrie (R-KY-2), Doris Matsui (D-CA-6) and Gus Bilirakis (R-FL-12) announced introduction of the Cancer Drug Parity Act, a bipartisan bill requiring health insurance plans that cover intravenous and injectable cancer medications to also cover orally administered cancer medications at the equivalent rate.
In a House of Representatives Budget Committee hearing reviewing the recently released 2020 budget proposed by President Trump, Budget Committee member Congressman Brian Higgins (NY-26) questioned the Administration’s justification for drastic cuts in medical research generally, and cancer research specifically.
In a news conference on Capitol Hill, Congressmembers Brian Higgins (NY-26), John Larson (CT-01), Joe Courtney (CT-02), and Peter Welch (VT-AL) announced plans to introduce the Medicare Buy-In and Health Care Stabilization Act. The legislation will expand access to Medicare to allow those aged 50-64 to buy into the highly successful and popular program, providing millions more Americans who are more likely to have pre-existing conditions and face premium increases as they near retirement with an option for affordable, quality health care.